Physician profile
Katherine E Specht
NPI 1073045647
$4,005.60
in general payments reported to CMS, 2019-2025
13 companies · $1,227 in 2025
The $1,227 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2021: $42.50 · 2022: $417 · 2023: $306 · 2024: $1,770 · 2025: $1,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,875 · Travel and Lodging: $1,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,874.93 |
| Travel and Lodging | $1,428.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,387.47 | 2022-2024 | Interstim |
| Intuitive Surgical, INC. | $940.58 | 2024-2025 | |
| Boston Scientific Corporation | $310.56 | 2021-2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Conmed Corporation | $276.64 | 2023-2024 | Airseal |
| Abbvie INC. | $227.32 | 2023-2024 | Skyrizi |
| Guard Medical INC. | $153.45 | 2022-2023 | Npseal (5), Npseal Large, Npseal Medium |
| Allergan, INC. | $140.83 | 2019 | |
| Incyte Corporation | $124.98 | 2025 | Zynyz |
| Rti Surgical, INC | $121.42 | 2024 | |
| Ucb, INC. | $104.84 | 2025 | |
| Merck Sharp & Dohme LLC | $102.01 | 2019 | |
| Aroa Biosurgery Incorporated | $85.21 | 2025 | |
| Goode Surgical INC | $30.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Specht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.